TreeWAS – Variant ID: rs4748185

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
K80.1 Calculus of gallbladder with other cholecystitis	0.000	0.997	0.003
C44 Other malignant neoplasms of skin	0.000	0.997	0.003
C44.6 Skin of upper limb, including shoulder	0.000	0.997	0.003
C44.3 Skin of other and unspecified parts of face	0.000	0.997	0.003
C44.7 Skin of lower limb, including hip	0.000	0.997	0.003
C44.5 Skin of trunk	0.000	0.997	0.003
K80 Cholelithiasis	0.000	0.997	0.003
E78.0 Pure hypercholesterolaemia	0.003	0.997	0.000
C44.0 Skin of lip	0.000	0.997	0.003
C44.2 Skin of ear and external auricular canal	0.000	0.997	0.002
C44.1 Skin of eyelid, including canthus	0.000	0.997	0.002
K80.0 Calculus of gallbladder with acute cholecystitis	0.000	0.997	0.003
C44.8 Overlapping lesion of skin	0.000	0.997	0.002
T36-T50 Poisoning by drugs, medicaments and biological substances	0.000	0.997	0.003
C44.9 Malignant neoplasm of skin, unspecified	0.000	0.997	0.002
C44.4 Skin of scalp and neck	0.000	0.997	0.002
K80.2 Calculus of gallbladder without cholecystitis	0.000	0.998	0.002
F32.9 Depressive episode, unspecified	0.000	0.998	0.002
K80.8 Other cholelithiasis	0.000	0.998	0.002
F32 Depressive episode	0.000	0.998	0.002
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]	0.000	0.998	0.002
K80.3 Calculus of bile duct with cholangitis	0.000	0.998	0.002
K80.5 Calculus of bile duct without cholangitis or cholecystitis	0.000	0.998	0.002
F30-F39 Mood [affective] disorders	0.000	0.998	0.002
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics	0.000	0.998	0.002
C43-C44 Melanoma and other malignant neoplasms of skin	0.000	0.998	0.002
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.000	0.998	0.002
T43 Poisoning by psychotropic drugs, not elsewhere classified	0.000	0.998	0.002
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.000	0.998	0.002
K80.4 Calculus of bile duct with cholecystitis	0.000	0.998	0.002
H15-H22 Disorders of sclera, cornea, iris and ciliary body	0.000	0.998	0.002
Chapter VII Diseases of the eye and adnexa	0.000	0.998	0.002
Chapter V Mental and behavioural disorders	0.000	0.998	0.002
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.000	0.998	0.002
Chapter XIX Injury, poisoning and certain other consequences of external causes	0.000	0.998	0.002
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.000	0.998	0.002
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.000	0.998	0.002
I30-I52 Other forms of heart disease	0.000	0.998	0.002
J30-J39 Other diseases of upper respiratory tract	0.000	0.998	0.002
T39.1 4-Aminophenol derivatives	0.000	0.998	0.002
T46 Poisoning by agents primarily affecting the cardiovascular system	0.000	0.998	0.002
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.000	0.998	0.002
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.000	0.998	0.002
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.000	0.998	0.002
T41 Poisoning by anaesthetics and therapeutic gases	0.000	0.998	0.002
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.000	0.998	0.002
H53-H54 Visual disturbances and blindness	0.000	0.998	0.002
N92.0 Excessive and frequent menstruation with regular cycle	0.002	0.998	0.000
T40.2 Other opioids	0.000	0.998	0.002
T36 Poisoning by systemic antibiotics	0.000	0.998	0.002
J38 Diseases of vocal cords and larynx, not elsewhere classified	0.000	0.998	0.002
J34 Other disorders of nose and nasal sinuses	0.000	0.998	0.002
S50-S59 Injuries to the elbow and forearm	0.000	0.998	0.002
H18 Other disorders of cornea	0.000	0.998	0.002
F32.2 Severe depressive episode without psychotic symptoms	0.000	0.998	0.002
T43.2 Other and unspecified antidepressants	0.000	0.998	0.002
F40-F48 Neurotic, stress-related and somatoform disorders	0.000	0.998	0.002
S20-S29 Injuries to the thorax	0.000	0.998	0.002
Chapter XVIII Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified	0.000	0.998	0.002
Chapter XII Diseases of the skin and subcutaneous tissue	0.000	0.998	0.002
H55-H59 Other disorders of eye and adnexa	0.000	0.998	0.002
F32.0 Mild depressive episode	0.000	0.998	0.002
I50.1 Left ventricular failure	0.000	0.998	0.002
J34.2 Deviated nasal septum	0.000	0.998	0.002
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified	0.000	0.998	0.002
H54 Blindness and low vision	0.000	0.998	0.002
H30-H36 Disorders of choroid and retina	0.000	0.998	0.002
J34.3 Hypertrophy of nasal turbinates	0.000	0.998	0.002
J38.3 Other diseases of vocal cords	0.000	0.998	0.002
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified	0.000	0.998	0.002
H21 Other disorders of iris and ciliary body	0.000	0.998	0.002
I45 Other conduction disorders	0.000	0.998	0.002
N92 Excessive, frequent and irregular menstruation	0.002	0.998	0.000
F32.1 Moderate depressive episode	0.000	0.998	0.002
T40.4 Other synthetic narcotics	0.000	0.998	0.002
H19 Disorders of sclera and cornea in diseases classified elsewhere	0.000	0.998	0.002
I50 Heart failure	0.000	0.998	0.002
I42 Cardiomyopathy	0.000	0.998	0.002
F60-F69 Disorders of adult personality and behaviour	0.000	0.998	0.002
H10-H13 Disorders of conjunctiva	0.000	0.998	0.002
R20-R23 Symptoms and signs involving the skin and subcutaneous tissue	0.000	0.998	0.002
Chapter X Diseases of the respiratory system	0.000	0.998	0.002
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.000	0.998	0.002
T44.9 Other and unspecified drugs primarily affecting the nervous system	0.000	0.998	0.002
F34 Persistent mood [affective] disorders	0.000	0.998	0.002
F33 Recurrent depressive disorder	0.000	0.998	0.002
H17 Corneal scars and opacities	0.000	0.998	0.002
J32 Chronic sinusitis	0.000	0.998	0.002
F00-F09 Organic, including symptomatic, mental disorders	0.000	0.998	0.002
L40-L45 Papulosquamous disorders	0.000	0.998	0.002
T51-T65 Toxic effects of substances chiefly nonmedicinal as to source	0.000	0.998	0.002
F32.8 Other depressive episodes	0.000	0.998	0.002
T42.6 Other antiepileptic and sedative-hypnotic drugs	0.000	0.998	0.002
F31 Bipolar affective disorder	0.000	0.998	0.002
H16 Keratitis	0.000	0.998	0.002
H43-H45 Disorders of vitreous body and globe	0.000	0.998	0.002
T66-T78 Other and unspecified effects of external causes	0.000	0.998	0.002
K80.36 Calculus of bile duct with acute and chronic cholangitis without obstruction	0.000	0.998	0.002
L40.9 Psoriasis, unspecified	0.000	0.998	0.002
T39.0 Salicylates	0.000	0.998	0.002
T40.9 Other and unspecified psychodysleptics [hallucinogens]	0.000	0.998	0.002
T40.8 Lysergide [LSD]	0.000	0.998	0.002
T40.7 Cannabis (derivatives)	0.000	0.998	0.002
T40.6 Other and unspecified narcotics	0.000	0.998	0.002
T40.5 Cocaine	0.000	0.998	0.002
T40.3 Methadone	0.000	0.998	0.002
T40.1 Heroin	0.000	0.998	0.002
T40.0 Opium	0.000	0.998	0.002
T43.5 Other and unspecified antipsychotics and neuroleptics	0.000	0.998	0.002
I31 Other diseases of pericardium	0.000	0.998	0.002
K80-K87 Disorders of gallbladder, biliary tract and pancreas	0.000	0.998	0.002
S80-S89 Injuries to the knee and lower leg	0.000	0.998	0.002
S40-S49 Injuries to the shoulder and upper arm	0.000	0.998	0.002
F32.3 Severe depressive episode with psychotic symptoms	0.000	0.998	0.002
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified	0.000	0.998	0.002
T39.4 Antirheumatics, not elsewhere classified	0.000	0.998	0.002
T39.2 Pyrazolone derivatives	0.000	0.998	0.002
E78 Disorders of lipoprotein metabolism and other lipidaemias	0.002	0.998	0.000
F38 Other mood [affective] disorders	0.000	0.998	0.002
F39 Unspecified mood [affective] disorder	0.000	0.998	0.002
R53 Malaise and fatigue	0.000	0.998	0.002
H46-H48 Disorders of optic nerve and visual pathways	0.000	0.998	0.002
L80-L99 Other disorders of the skin and subcutaneous tissue	0.000	0.998	0.002
N92.1 Excessive and frequent menstruation with irregular cycle	0.002	0.998	0.000
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified	0.000	0.998	0.002
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified	0.000	0.998	0.002
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified	0.000	0.998	0.002
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.000	0.998	0.002
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.000	0.998	0.002
T44.2 Ganglionic blocking drugs, not elsewhere classified	0.000	0.998	0.002
T44.1 Other parasympathomimetics [cholinergics]	0.000	0.998	0.002
T44.0 Anticholinesterase agents	0.000	0.998	0.002
C43 Malignant melanoma of skin	0.000	0.998	0.002
F30 Manic episode	0.000	0.998	0.002
F41 Other anxiety disorders	0.000	0.998	0.002
H33 Retinal detachments and breaks	0.000	0.998	0.002
I51 Complications and ill-defined descriptions of heart disease	0.000	0.998	0.002
F99-F99 Unspecified mental disorder	0.000	0.998	0.002
F50-F59 Behavioural syndromes associated with physiological disturbances and physical factors	0.000	0.998	0.002
T90-T98 Sequelae of injuries, of poisoning and of other consequences of external causes	0.000	0.998	0.002
T79-T79 Certain early complications of trauma	0.000	0.998	0.002
T00-T07 Injuries involving multiple body regions	0.000	0.998	0.002
R40-R46 Symptoms and signs involving cognition, perception, emotional state and behaviour	0.000	0.998	0.002
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants	0.000	0.998	0.002
T42.5 Mixed antiepileptics, not elsewhere classified	0.000	0.998	0.002
T42.3 Barbiturates	0.000	0.998	0.002
T42.2 Succinimides and oxazolidinediones	0.000	0.998	0.002
T42.1 Iminostilbenes	0.000	0.998	0.002
T42.0 Hydantoin derivatives	0.000	0.998	0.002
T43.9 Psychotropic drug, unspecified	0.000	0.998	0.002
T43.8 Other psychotropic drugs, not elsewhere classified	0.000	0.998	0.002
T43.6 Psychostimulants with abuse potential	0.000	0.998	0.002
T43.4 Butyrophenone and thioxanthene neuroleptics	0.000	0.998	0.002
T43.1 Monoamine-oxidase-inhibitor antidepressants	0.000	0.998	0.002
T43.0 Tricyclic and tetracyclic antidepressants	0.000	0.998	0.002
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified	0.000	0.998	0.002
T47.0 Histamine H(2)-receptor antagonists	0.000	0.998	0.002
H22 Disorders of iris and ciliary body in diseases classified elsewhere	0.000	0.998	0.002
H57 Other disorders of eye and adnexa	0.000	0.998	0.002
I49 Other cardiac arrhythmias	0.000	0.998	0.002
I34 Nonrheumatic mitral valve disorders	0.000	0.998	0.002
L40 Psoriasis	0.000	0.998	0.002
F10-F19 Mental and behavioural disorders due to psychoactive substance use	0.000	0.998	0.002
H40-H42 Glaucoma	0.000	0.998	0.002
H00-H06 Disorders of eyelid, lacrimal system and orbit	0.000	0.998	0.002
J90-J94 Other diseases of pleura	0.000	0.998	0.002
T20-T25 Burns and corrosions of external body surface, specified by site	0.000	0.998	0.002
S10-S19 Injuries to the neck	0.000	0.998	0.002
R00-R09 Symptoms and signs involving the circulatory and respiratory systems	0.000	0.998	0.002
# Top node	0.000	0.998	0.002
J38.7 Other diseases of larynx	0.000	0.998	0.002
T43.3 Phenothiazine antipsychotics and neuroleptics	0.000	0.998	0.002
H15 Disorders of sclera	0.000	0.998	0.002
I35 Nonrheumatic aortic valve disorders	0.000	0.998	0.002
J33 Nasal polyp	0.000	0.998	0.002
R05 Cough	0.000	0.998	0.002
S56 Injury of muscle and tendon at forearm level	0.000	0.998	0.002
I70-I79 Diseases of arteries, arterioles and capillaries	0.000	0.998	0.002
F90-F98 Behavioural and emotional disorders with onset usually occurring in childhood and adolescence	0.000	0.998	0.002
F70-F79 Mental retardation	0.000	0.998	0.002
T33-T35 Frostbite	0.000	0.998	0.002
T29-T32 Burns and corrosions of multiple and unspecified body regions	0.000	0.998	0.002
T26-T28 Burns and corrosions confined to eye and internal organs	0.000	0.998	0.002
S30-S39 Injuries to the abdomen, lower back, lumbar spine and pelvis	0.000	0.998	0.002
H18.3 Changes in corneal membranes	0.000	0.998	0.002
T38.9 Other and unspecified hormone antagonists	0.000	0.998	0.002
T38.8 Other and unspecified hormones and their synthetic substitutes	0.000	0.998	0.002
T38.7 Androgens and anabolic congeners	0.000	0.998	0.002
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified	0.000	0.998	0.002
T38.5 Other oestrogens and progestogens	0.000	0.998	0.002
T38.4 Oral contraceptives	0.000	0.998	0.002
T38.2 Antithyroid drugs	0.000	0.998	0.002
T38.1 Thyroid hormones and substitutes	0.000	0.998	0.002
T38.0 Glucocorticoids and synthetic analogues	0.000	0.998	0.002
T42.4 Benzodiazepines	0.000	0.998	0.002
T45.0 Antiallergic and antiemetic drugs	0.000	0.998	0.002
T46.2 Other antidysrhythmic drugs, not elsewhere classified	0.000	0.998	0.002
H53 Visual disturbances	0.000	0.998	0.002
I40 Acute myocarditis	0.000	0.998	0.002
F80-F89 Disorders of psychological development	0.000	0.998	0.002
F17.1 Harmful use	0.000	0.998	0.002
H54.4 Blindness, one eye	0.000	0.998	0.002
I45.1 Other and unspecified right bundle-branch block	0.000	0.998	0.002
J32.9 Chronic sinusitis, unspecified	0.000	0.998	0.002
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.000	0.998	0.002
F17 Mental and behavioural disorders due to use of tobacco	0.000	0.998	0.002
H20 Iridocyclitis	0.000	0.998	0.002
I44 Atrioventricular and left bundle-branch block	0.000	0.998	0.002
I30 Acute pericarditis	0.000	0.998	0.002
L98 Other disorders of skin and subcutaneous tissue, not elsewhere classified	0.000	0.998	0.002
R21 Rash and other nonspecific skin eruption	0.000	0.998	0.002
S51 Open wound of forearm	0.000	0.998	0.002
F20-F29 Schizophrenia, schizotypal and delusional disorders	0.000	0.998	0.002
S90-S99 Injuries to the ankle and foot	0.000	0.998	0.002
R83-R89 Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis	0.000	0.998	0.002
H33.3 Retinal breaks without detachment	0.000	0.998	0.002
I78.1 Naevus, nonneoplastic	0.000	0.998	0.002
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.000	0.998	0.002
T47.8 Other agents primarily affecting the gastro-intestinal system	0.000	0.998	0.002
T47.7 Emetics	0.000	0.998	0.002
T47.6 Antidiarrhoeal drugs	0.000	0.998	0.002
T47.5 Digestants	0.000	0.998	0.002
T47.4 Other laxatives	0.000	0.998	0.002
T47.3 Saline and osmotic laxatives	0.000	0.998	0.002
T47.2 Stimulant laxatives	0.000	0.998	0.002
H11 Other disorders of conjunctiva	0.000	0.998	0.002
I52 Other heart disorders in diseases classified elsewhere	0.000	0.998	0.002
I48 Atrial fibrillation and flutter	0.000	0.998	0.002
I41 Myocarditis in diseases classified elsewhere	0.000	0.998	0.002
I39 Endocarditis and heart valve disorders in diseases classified elsewhere	0.000	0.998	0.002
I32 Pericarditis in diseases classified elsewhere	0.000	0.998	0.002
T15-T19 Effects of foreign body entering through natural orifice	0.000	0.998	0.002
T08-T14 Injuries to unspecified part of trunk, limb or body region	0.000	0.998	0.002
S70-S79 Injuries to the hip and thigh	0.000	0.998	0.002
Chapter IX Diseases of the circulatory system	0.000	0.998	0.002
J38.2 Nodules of vocal cords	0.000	0.998	0.002
N92.3 Ovulation bleeding	0.002	0.998	0.000
T45.9 Primarily systemic and haematological agent, unspecified	0.000	0.998	0.002
T45.8 Other primarily systemic and haematological agents	0.000	0.998	0.002
T45.7 Anticoagulant antagonists, vitamin K and other coagulants	0.000	0.998	0.002
T45.6 Fibrinolysis-affecting drugs	0.000	0.998	0.002
T45.5 Anticoagulants	0.000	0.998	0.002
T45.4 Iron and its compounds	0.000	0.998	0.002
T45.3 Enzymes, not elsewhere classified	0.000	0.998	0.002
T45.2 Vitamins, not elsewhere classified	0.000	0.998	0.002
T45.1 Antineoplastic and immunosuppressive drugs	0.000	0.998	0.002
T46.9 Other and unspecified agents primarily affecting the cardiovascular system	0.000	0.998	0.002
T46.8 Antivaricose drugs, including sclerosing agents	0.000	0.998	0.002
T46.7 Peripheral vasodilators	0.000	0.998	0.002
T46.5 Other antihypertensive drugs, not elsewhere classified	0.000	0.998	0.002
T46.3 Coronary vasodilators, not elsewhere classified	0.000	0.998	0.002
T46.0 Cardiac-stimulant glycosides and drugs of similar action	0.000	0.998	0.002
T47.1 Other antacids and anti-gastric-secretion drugs	0.000	0.998	0.002
T50.9 Other and unspecified drugs, medicaments and biological substances	0.000	0.998	0.002
I43 Cardiomyopathy in diseases classified elsewhere	0.000	0.998	0.002
I37 Pulmonary valve disorders	0.000	0.998	0.002
I36 Nonrheumatic tricuspid valve disorders	0.000	0.998	0.002
I78 Diseases of capillaries	0.000	0.998	0.002
J37 Chronic laryngitis and laryngotracheitis	0.000	0.998	0.002
J36 Peritonsillar abscess	0.000	0.998	0.002
S20 Superficial injury of thorax	0.000	0.998	0.002
S52 Fracture of forearm	0.000	0.998	0.002
H18.1 Bullous keratopathy	0.000	0.998	0.002
H18.0 Corneal pigmentations and deposits	0.000	0.998	0.002
H54.9 Unspecified visual impairment (binocular)	0.000	0.998	0.002
I42.9 Cardiomyopathy, unspecified	0.000	0.998	0.002
I51.8 Other ill-defined heart diseases	0.000	0.998	0.002
J34.0 Abscess, furuncle and carbuncle of nose	0.000	0.998	0.002
J38.1 Polyp of vocal cord and larynx	0.000	0.998	0.002
T37.9 Systemic anti-infective and antiparasitic, unspecified	0.000	0.998	0.002
T37.8 Other specified systemic anti-infectives and antiparasitics	0.000	0.998	0.002
T37.5 Antiviral drugs	0.000	0.998	0.002
T37.4 Anthelminthics	0.000	0.998	0.002
T37.3 Other antiprotozoal drugs	0.000	0.998	0.002
T37.2 Antimalarials and drugs acting on other blood protozoa	0.000	0.998	0.002
T37.1 Antimycobacterial drugs	0.000	0.998	0.002
T37.0 Sulphonamides	0.000	0.998	0.002
T41.5 Therapeutic gases	0.000	0.998	0.002
T41.4 Anaesthetic, unspecified	0.000	0.998	0.002
T41.3 Local anaesthetics	0.000	0.998	0.002
T41.2 Other and unspecified general anaesthetics	0.000	0.998	0.002
T41.1 Intravenous anaesthetics	0.000	0.998	0.002
T41.0 Inhaled anaesthetics	0.000	0.998	0.002
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.000	0.998	0.002
T46.4 Angiotensin-converting-enzyme inhibitors	0.000	0.998	0.002
T46.1 Calcium-channel blockers	0.000	0.998	0.002
T48.7 Other and unspecified agents primarily acting on the respiratory system	0.000	0.998	0.002
T48.6 Antiasthmatics, not elsewhere classified	0.000	0.998	0.002
T48.5 Anti-common-cold drugs	0.000	0.998	0.002
T48.4 Expectorants	0.000	0.998	0.002
T48.3 Antitussives	0.000	0.998	0.002
T48.2 Other and unspecified agents primarily acting on muscles	0.000	0.998	0.002
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.000	0.998	0.002
T48.0 Oxytocic drugs	0.000	0.998	0.002
T49.9 Topical agent, unspecified	0.000	0.998	0.002
T49.8 Other topical agents	0.000	0.998	0.002
T49.7 Dental drugs, topically applied	0.000	0.998	0.002
T49.6 Otorhinolaryngological drugs and preparations	0.000	0.998	0.002
T49.5 Ophthalmological drugs and preparations	0.000	0.998	0.002
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.000	0.998	0.002
T49.3 Emollients, demulcents and protectants	0.000	0.998	0.002
T49.2 Local astringents and local detergents	0.000	0.998	0.002
T49.1 Antipruritics	0.000	0.998	0.002
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.000	0.998	0.002
T50.8 Diagnostic agents	0.000	0.998	0.002
T50.7 Analeptics and opioid receptor antagonists	0.000	0.998	0.002
T50.6 Antidotes and chelating agents, not elsewhere classified	0.000	0.998	0.002
T50.5 Appetite depressants	0.000	0.998	0.002
T50.4 Drugs affecting uric acid metabolism	0.000	0.998	0.002
T50.3 Electrolytic, caloric and water-balance agents	0.000	0.998	0.002
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics	0.000	0.998	0.002
T50.1 Loop [high-ceiling] diuretics	0.000	0.998	0.002
T50.0 Mineralocorticoids and their antagonists	0.000	0.998	0.002
I33 Acute and subacute endocarditis	0.000	0.998	0.002
J35 Chronic diseases of tonsils and adenoids	0.000	0.998	0.002
R42 Dizziness and giddiness	0.000	0.998	0.002
S53 Dislocation, sprain and strain of joints and ligaments of elbow	0.000	0.998	0.002
L55-L59 Radiation-related disorders of the skin and subcutaneous tissue	0.000	0.998	0.002
T36.9 Systemic antibiotic, unspecified	0.000	0.998	0.002
T36.8 Other systemic antibiotics	0.000	0.998	0.002
T36.7 Antifungal antibiotics, systemically used	0.000	0.998	0.002
T36.6 Rifamycins	0.000	0.998	0.002
T36.5 Aminoglycosides	0.000	0.998	0.002
T36.4 Tetracyclines	0.000	0.998	0.002
T36.3 Macrolides	0.000	0.998	0.002
T36.2 Chloramphenicol group	0.000	0.998	0.002
T36.1 Cefalosporins and other Beta-lactam antibiotics	0.000	0.998	0.002
T36.0 Penicillins	0.000	0.998	0.002
J39 Other diseases of upper respiratory tract	0.000	0.998	0.002
L97 Ulcer of lower limb, not elsewhere classified	0.000	0.998	0.002
R20 Disturbances of skin sensation	0.000	0.998	0.002
R40 Somnolence, stupor and coma	0.000	0.998	0.002
S27 Injury of other and unspecified intrathoracic organs	0.000	0.998	0.002
T51 Toxic effect of alcohol	0.000	0.998	0.002
J80-J84 Other respiratory diseases principally affecting the interstitium	0.000	0.998	0.002
J00-J06 Acute upper respiratory infections	0.000	0.998	0.002
L00-L08 Infections of the skin and subcutaneous tissue	0.000	0.998	0.002
E66.9 Obesity, unspecified	0.000	0.998	0.002
H18.5 Hereditary corneal dystrophies	0.000	0.998	0.002
H54.6 Unqualified visual loss, one eye	0.000	0.998	0.002
I42.0 Dilated cardiomyopathy	0.000	0.998	0.002
J38.6 Stenosis of larynx	0.000	0.998	0.002
J38.5 Laryngeal spasm	0.000	0.998	0.002
F48 Other neurotic disorders	0.000	0.998	0.002
F60 Specific personality disorders	0.000	0.998	0.002
H43 Disorders of vitreous body	0.000	0.998	0.002
I46 Cardiac arrest	0.000	0.998	0.002
I38 Endocarditis, valve unspecified	0.000	0.998	0.002
J31 Chronic rhinitis, nasopharyngitis and pharyngitis	0.000	0.998	0.002
K82 Other diseases of gallbladder	0.000	0.998	0.002
S58 Traumatic amputation of forearm	0.000	0.998	0.002
S57 Crushing injury of forearm	0.000	0.998	0.002
H49-H52 Disorders of ocular muscles, binocular movement, accommodation and refraction	0.000	0.998	0.002
F41.2 Mixed anxiety and depressive disorder	0.000	0.998	0.002
H16.0 Corneal ulcer	0.000	0.998	0.002
H57.1 Ocular pain	0.000	0.998	0.002
I45.3 Trifascicular block	0.000	0.998	0.002
I45.2 Bifascicular block	0.000	0.998	0.002
J34.1 Cyst and mucocele of nose and nasal sinus	0.000	0.998	0.002
J38.4 Oedema of larynx	0.000	0.998	0.002
J38.0 Paralysis of vocal cords and larynx	0.000	0.998	0.002
F43 Reaction to severe stress, and adjustment disorders	0.000	0.998	0.002
H05 Disorders of orbit	0.000	0.998	0.002
I73 Other peripheral vascular diseases	0.000	0.998	0.002
J30 Vasomotor and allergic rhinitis	0.000	0.998	0.002
L43 Lichen planus	0.000	0.998	0.002
R00 Abnormalities of heart beat	0.000	0.998	0.002
S29 Other and unspecified injuries of thorax	0.000	0.998	0.002
S22 Fracture of rib(s), sternum and thoracic spine	0.000	0.998	0.002
S59 Other and unspecified injuries of forearm	0.000	0.998	0.002
S55 Injury of blood vessels at forearm level	0.000	0.998	0.002
S54 Injury of nerves at forearm level	0.000	0.998	0.002
S80 Superficial injury of lower leg	0.000	0.998	0.002
T93 Sequelae of injuries of lower limb	0.000	0.998	0.002
J60-J70 Lung diseases due to external agents	0.000	0.998	0.002
R50-R69 General symptoms and signs	0.000	0.998	0.002
F33.9 Recurrent depressive disorder, unspecified	0.000	0.998	0.002
H17.8 Other corneal scars and opacities	0.000	0.998	0.002
H18.9 Disorder of cornea, unspecified	0.000	0.998	0.002
H18.8 Other specified disorders of cornea	0.000	0.998	0.002
H18.7 Other corneal deformities	0.000	0.998	0.002
H18.6 Keratoconus	0.000	0.998	0.002
H18.2 Other corneal oedema	0.000	0.998	0.002
H19.2 Keratitis and keratoconjunctivitis in other infectious and parasitic diseases classified elsewhere	0.000	0.998	0.002
H19.1 Herpesviral keratitis and keratoconjunctivitis	0.000	0.998	0.002
H21.8 Other specified disorders of iris and ciliary body	0.000	0.998	0.002
H21.5 Other adhesions and disruptions of iris and ciliary body	0.000	0.998	0.002
H21.0 Hyphaema	0.000	0.998	0.002
I31.3 Pericardial effusion (noninflammatory)	0.000	0.998	0.002
I42.8 Other cardiomyopathies	0.000	0.998	0.002
I73.9 Peripheral vascular disease, unspecified	0.000	0.998	0.002
N92.4 Excessive bleeding in the premenopausal period	0.002	0.998	0.000
R00.2 Palpitations	0.000	0.998	0.002
F02 Dementia in other diseases classified elsewhere	0.000	0.998	0.002
H36 Retinal disorders in diseases classified elsewhere	0.000	0.998	0.002
H59 Postprocedural disorders of eye and adnexa, not elsewhere classified	0.000	0.998	0.002
L90 Atrophic disorders of skin	0.000	0.998	0.002
R22 Localised swelling, mass and lump of skin and subcutaneous tissue	0.000	0.998	0.002
S28 Crushing injury of thorax and traumatic amputation of part of thorax	0.000	0.998	0.002
S26 Injury of heart	0.000	0.998	0.002
S25 Injury of blood vessels of thorax	0.000	0.998	0.002
S50 Superficial injury of forearm	0.000	0.998	0.002
S83 Dislocation, sprain and strain of joints and ligaments of knee	0.000	0.998	0.002
L60-L75 Disorders of skin appendages	0.000	0.998	0.002
R95-R99 Ill-defined and unknown causes of mortality	0.000	0.998	0.002
R90-R94 Abnormal findings on diagnostic imaging and in function studies, without diagnosis	0.000	0.998	0.002
F31.9 Bipolar affective disorder, unspecified	0.000	0.998	0.002
F33.2 Recurrent depressive disorder, current episode severe without psychotic symptoms	0.000	0.998	0.002
F34.1 Dysthymia	0.000	0.998	0.002
H17.9 Corneal scar and opacity, unspecified	0.000	0.998	0.002
H18.4 Corneal degeneration	0.000	0.998	0.002
H54.7 Unspecified visual loss	0.000	0.998	0.002
I45.6 Preexcitation syndrome	0.000	0.998	0.002
F03 Unspecified dementia	0.000	0.998	0.002
F45 Somatoform disorders	0.000	0.998	0.002
F44 Dissociative [conversion] disorders	0.000	0.998	0.002
F68 Other disorders of adult personality and behaviour	0.000	0.998	0.002
S24 Injury of nerves and spinal cord at thorax level	0.000	0.998	0.002
S23 Dislocation, sprain and strain of joints and ligaments of thorax	0.000	0.998	0.002
S21 Open wound of thorax	0.000	0.998	0.002
S42 Fracture of shoulder and upper arm	0.000	0.998	0.002
T78 Adverse effects, not elsewhere classified	0.000	0.998	0.002
L50-L54 Urticaria and erythema	0.000	0.998	0.002
L10-L14 Bullous disorders	0.000	0.998	0.002
F31.4 Bipolar affective disorder, current episode severe depression without psychotic symptoms	0.000	0.998	0.001
F41.0 Panic disorder [episodic paroxysmal anxiety]	0.000	0.998	0.002
H54.5 Low vision, one eye	0.000	0.998	0.002
H54.3 Unqualified visual loss, both eyes	0.000	0.998	0.002
H54.2 Low vision, both eyes	0.000	0.998	0.002
H54.1 Blindness, one eye, low vision, other eye	0.000	0.998	0.002
I31.9 Disease of pericardium, unspecified	0.000	0.998	0.002
I45.4 Nonspecific intraventricular block	0.000	0.998	0.002
I45.0 Right fascicular block	0.000	0.998	0.002
J32.4 Chronic pansinusitis	0.000	0.998	0.002
J32.2 Chronic ethmoidal sinusitis	0.000	0.998	0.002
N92.2 Excessive menstruation at puberty	0.002	0.998	0.000
S56.8 Injury of other and unspecified muscles and tendons at forearm level	0.000	0.998	0.002
F07 Personality and behavioural disorders due to brain disease, damage and dysfunction	0.000	0.998	0.002
F42 Obsessive-compulsive disorder	0.000	0.998	0.002
H32 Chorioretinal disorders in diseases classified elsewhere	0.000	0.998	0.002
H30 Chorioretinal inflammation	0.000	0.998	0.002
H58 Other disorders of eye and adnexa in diseases classified elsewhere	0.000	0.998	0.002
J90 Pleural effusion, not elsewhere classified	0.000	0.998	0.002
L08 Other local infections of skin and subcutaneous tissue	0.000	0.998	0.002
R45 Symptoms and signs involving emotional state	0.000	0.998	0.002
R87 Abnormal findings in specimens from female genital organs	0.000	0.998	0.002
T59 Toxic effect of other gases, fumes and vapours	0.000	0.998	0.002
T68 Hypothermia	0.000	0.998	0.002
J95-J99 Other diseases of the respiratory system	0.000	0.998	0.002
R80-R82 Abnormal findings on examination of urine, without diagnosis	0.000	0.998	0.002
R70-R79 Abnormal findings on examination of blood, without diagnosis	0.000	0.998	0.002
R25-R29 Symptoms and signs involving the nervous and musculoskeletal systems	0.000	0.998	0.002
H17.1 Other central corneal opacity	0.000	0.998	0.001
H17.0 Adherent leukoma	0.000	0.998	0.001
H19.8 Other disorders of sclera and cornea in diseases classified elsewhere	0.000	0.998	0.001
H19.0 Scleritis and episcleritis in diseases classified elsewhere	0.000	0.998	0.001
H21.9 Disorder of iris and ciliary body, unspecified	0.000	0.998	0.001
H21.4 Pupillary membranes	0.000	0.998	0.001
H21.3 Cyst of iris, ciliary body and anterior chamber	0.000	0.998	0.001
H21.2 Degeneration of iris and ciliary body	0.000	0.998	0.001
H21.1 Other vascular disorders of iris and ciliary body	0.000	0.998	0.001
I42.7 Cardiomyopathy due to drugs and other external agents	0.000	0.998	0.002
I42.5 Other restrictive cardiomyopathy	0.000	0.998	0.002
I42.4 Endocardial fibroelastosis	0.000	0.998	0.002
I42.3 Endomyocardial (eosinophilic) disease	0.000	0.998	0.002
I45.9 Conduction disorder, unspecified	0.000	0.998	0.001
I45.8 Other specified conduction disorders	0.000	0.998	0.002
I45.5 Other specified heart block	0.000	0.998	0.002
S20.8 Superficial injuries of other and unspecified parts of thorax	0.000	0.998	0.002
S52.0 Fracture of upper end of ulna	0.000	0.998	0.002
T51.0 Ethanol	0.000	0.998	0.002
F01 Vascular dementia	0.000	0.998	0.002
F66 Psychological and behavioural disorders associated with sexual development and orientation	0.000	0.998	0.001
F65 Disorders of sexual preference	0.000	0.998	0.001
F64 Gender identity disorders	0.000	0.998	0.001
F63 Habit and impulse disorders	0.000	0.998	0.001
F62 Enduring personality changes, not attributable to brain damage and disease	0.000	0.998	0.001
F69 Unspecified disorder of adult personality and behaviour	0.000	0.998	0.001
F61 Mixed and other personality disorders	0.000	0.998	0.001
H01 Other inflammation of eyelid	0.000	0.998	0.002
H13 Disorders of conjunctiva in diseases classified elsewhere	0.000	0.998	0.001
H34 Retinal vascular occlusions	0.000	0.998	0.002
H31 Other disorders of choroid	0.000	0.998	0.002
H47 Other disorders of optic [2nd] nerve and visual pathways	0.000	0.998	0.002
H55 Nystagmus and other irregular eye movements	0.000	0.998	0.001
J94 Other pleural conditions	0.000	0.998	0.002
L89 Decubitus ulcer	0.000	0.998	0.002
S43 Dislocation, sprain and strain of joints and ligaments of shoulder girdle	0.000	0.998	0.002
T97 Sequelae of toxic effects of substances chiefly nonmedicinal as to source	0.000	0.998	0.002
L20-L30 Dermatitis and eczema	0.000	0.998	0.002
N80-N98 Noninflammatory disorders of female genital tract	0.002	0.998	0.000
R47-R49 Symptoms and signs involving speech and voice	0.000	0.998	0.002
R30-R39 Symptoms and signs involving the urinary system	0.000	0.998	0.002
C43.1 Malignant melanoma of eyelid, including canthus	0.000	0.998	0.001
F33.8 Other recurrent depressive disorders	0.000	0.998	0.001
F33.4 Recurrent depressive disorder, currently in remission	0.000	0.998	0.001
F33.3 Recurrent depressive disorder, current episode severe with psychotic symptoms	0.000	0.998	0.001
F33.0 Recurrent depressive disorder, current episode mild	0.000	0.998	0.001
F34.9 Persistent mood [affective] disorder, unspecified	0.000	0.998	0.001
F34.8 Other persistent mood [affective] disorders	0.000	0.998	0.001

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations